Hao CM - Search Results

1

Glycogen synthase kinase 3 inhibition improves insulin-stimulated glucose metabolism but not hypertension in high-fat-fed C57BL/6J mice.

Rao R, Hao CM, Redha R, Wasserman DH, McGuinness OP, Breyer MD. Rao R, et al. Among authors: hao cm. Diabetologia. 2007 Feb;50(2):452-60. doi: 10.1007/s00125-006-0552-5. Epub 2006 Dec 7. Diabetologia. 2007. PMID: 17151860

2

Physiologic and pathophysiologic roles of lipid mediators in the kidney.

Hao CM, Breyer MD. Hao CM, et al. Kidney Int. 2007 Jun;71(11):1105-15. doi: 10.1038/sj.ki.5002192. Epub 2007 Mar 14. Kidney Int. 2007. PMID: 17361113 Free article. Review.

3

Obinutuzumab treatment for membranous nephropathy: effectiveness and safety concerns during the COVID-19 pandemic.

Xu M, Chen R, Wang Y, Huang X, Zhang H, Zhao W, Zhang M, Xu Y, Liu S, Hao CM, Xie Q. Xu M, et al. Among authors: hao cm. Clin Kidney J. 2024 Oct 4;17(11):sfae299. doi: 10.1093/ckj/sfae299. eCollection 2024 Nov. Clin Kidney J. 2024. PMID: 39507289 Free PMC article.

4

Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy.

Xu M, Wang Y, Wu M, Chen R, Zhao W, Li M, Hao CM, Xie Q. Xu M, et al. Among authors: hao cm. Nephrol Dial Transplant. 2024 Oct 14:gfae230. doi: 10.1093/ndt/gfae230. Online ahead of print. Nephrol Dial Transplant. 2024. PMID: 39400696

5

Changes in the spectrum of biopsy-proven renal diseases over 11 years: a single-center study in China.

Wang Y, Zhang L, Yuan L, Xie Q, Liu S, Hao CM. Wang Y, et al. Among authors: hao cm. Ren Fail. 2024 Dec;46(2):2381614. doi: 10.1080/0886022X.2024.2381614. Epub 2024 Jul 22. Ren Fail. 2024. PMID: 39039852 Free PMC article.

6

Retroperitoneal leakage as an important cause of acquired ultrafiltration decline in peritoneal dialysis: clinical characteristics and related risk factors.

Chen Y, Zhang M, Li Y, Xie Q, Dai S, Ge X, Hao CM, Zhu T. Chen Y, et al. Among authors: hao cm. J Nephrol. 2024 Sep;37(7):1997-2005. doi: 10.1007/s40620-024-02009-3. Epub 2024 Jul 13. J Nephrol. 2024. PMID: 38997573

7

Case report: BTK inhibitors is effective in type II mixed cryoglobulinemia with wild-type MyD88.

Xu M, Xu Y, Yuan L, Shang D, Chen R, Liu S, Li Y, Liu A, Liu R, Wang Q, Ding T, Xie Q, Hao CM. Xu M, et al. Among authors: hao cm. Front Immunol. 2024 May 3;15:1390958. doi: 10.3389/fimmu.2024.1390958. eCollection 2024. Front Immunol. 2024. PMID: 38765016 Free PMC article.

8

Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions.

Cheng P, Xie Q, Liu S, Liu X, Wang L, Hao CM. Cheng P, et al. Among authors: hao cm. Rev Assoc Med Bras (1992). 2024 May 3;70(4):e20230871. doi: 10.1590/1806-9282.20230871. eCollection 2024. Rev Assoc Med Bras (1992). 2024. PMID: 38716932 Free PMC article.

9

Collecting duct NCOR1 controls blood pressure by regulating mineralocorticoid receptor.

Sun K, Wang YL, Hou CC, Shang D, Du LJ, Bai L, Zhang XY, Hao CM, Duan SZ. Sun K, et al. Among authors: hao cm. J Adv Res. 2024 Feb 8:S2090-1232(24)00053-5. doi: 10.1016/j.jare.2024.02.003. Online ahead of print. J Adv Res. 2024. PMID: 38341030 Free article.

10

Prostacyclin Mitigates Renal Fibrosis by Activating Fibroblast Prostaglandin I 2 Receptor.

Li J, Guan Y, Xu Y, Cao Y, Xie Q, Harris RC, Breyer MD, Lu L, Hao CM. Li J, et al. Among authors: hao cm. J Am Soc Nephrol. 2024 Feb 1;35(2):149-165. doi: 10.1681/ASN.0000000000000286. Epub 2023 Dec 8. J Am Soc Nephrol. 2024. PMID: 38062563

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

113 results

Search Page

Filters